Calyptus Pharmaceuticals
Princeton, US · Founded 2017 · Delaware corporation
Biotech
Founders & leadership
SK
Sujeet K. SinghNamed on SEC filing
SS
Sinharoy ShubhayuNamed on SEC filing
PY
Puiho YuenNamed on SEC filing
Reported raises · per SEC filings
Form D private placements$2.9M disclosed across 1 round · 2018
▶$2.9MraisedMay 2018 · 30 investors · PharmaceuticalsRule 506(b)
▶$2.9MraisedMay 2018 · 30 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Sujeet K. SinghExecutive Officer, Director, Promoter
- Sinharoy ShubhayuExecutive Officer, Director, Promoter
- Puiho YuenExecutive Officer, Director, Promoter
- Offering amount
- $3.7M
- Amount sold
- $2.9M
- Minimum investment
- $25K
- First sale
- May 2018
- Incorporated
- Corporation, Delaware, 2017
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- How much funding has Calyptus Pharmaceuticals raised?
- Calyptus Pharmaceuticals has disclosed $2.9M raised across 1 round.
- Where is Calyptus Pharmaceuticals headquartered?
- Calyptus Pharmaceuticals is headquartered in Princeton, US.